Potential gene therapy for late-stage Parkinson's side-effects uncovered
by Melissa Rohman,Northwestern UniversityAntagonism of A2aR and knockdown of GluN2B-NMDARs in iSPNs attenuate LID behaviors. Credit:Neuron(2026). DOI: 10.1016/j.neuron.2026.04.023Northwestern Medicine
Updated on: June 24,2026
Potential gene therapy for late-stage Parkinson's side-effects uncovered
by Melissa Rohman,Northwestern UniversityAntagonism of A2aR and knockdown of GluN2B-NMDARs in iSPNs attenuate LID behaviors. Credit:Neuron(2026). DOI: 10.1016/j.neuron.2026.04.023Northwestern Medicine
Updated on:June 24,2026
